Author | Disease | Data source | Centres | Study dates | Age range | Primary outcome(s) | Missing data | ML method (best model) | Validation | Prospective study/RCT | |
Internal | External | ||||||||||
Hogan et al 202121 | Asthma | Registry (National Database) | NR | 2013 | 5–18 | Hospitalisation | Complete case analysis | ANN | Yes | No | No |
Filipow et al 202122 | CF | Registry (Regional Database) | 1 | 2000–2018 | 2–18 | Hospitalisation, exacerbation | Complete case analysis | Cluster Analysis | Yes | Yes | No |
Bose et al 202130 | Asthma | Registry (EHR) | 30+ | 2005–2016 | 2–5 | Asthma persistence | Mixed | XGBoost | Yes | No | No |
van Horck et al 202138 | CF | Study data | 3 | NR | 5–18 | Exacerbation | NR | Random Forest | No | No | No |
Raita et al 202125 | Bronchi-olitis | Study data | 17 | 2011–2014 | <1 | Wheeze, asthma | Imputed | Cluster Analysis | No | No | No |
Sills et al 202126 | Asthma | Registry (EHR) | 5 | 2009–2013 | 2–21 | Hospitalisation | Complete case analysis | AutoML | Yes | No | No |
Seol et al 202129 | Asthma | NR | 1 | NR | <18 | Exacerbation | NR | Naïve Bayes | Yes | No | Yes |
Lovrić et al 202142 | Asthma | Study data | 1 | NR | 2–22 | Response to treatment | Imputed | AdaBoost | Yes | No | No |
Caparrós-Martín et al 202044 | CF | Study data | NR | NR | 2.5–4.4 | Lung damage (quantified CT) | NR | Cluster Analysis | No | No | No |
Wang et al 201931 | Asthma | Study data | 8 | 1993–1995 | 5–12 | Asthma remission | Complete case analysis | Decision Tree | No | No | No |
Messinger et al 201932 | Asthma | Registry (EHR) | 1 | 2016–2017 | 2–18 | Paediatric Asthma Score | Complete case analysis | ANN | Yes | No | No |
Khasha et al 201945 | Asthma | Study data | 1 | NR | >5 | Asthma control | Imputed | Ensemble Learning | No | No | No |
Goto et al 201933 | Asthma | Registry (National Database) | NR | 2007–2015 | 2–14 (IQR) | Critical care (admission to intensive care unit or death), hospitalisation | Imputed | Decision Tree | Yes | No | No |
Patel et al 201834 | Asthma | Registry (EHR) | 2 | 2012–2015 | 2–18 | Hospitalisation | Complete case analysis | Gradient Boosting | Yes | No | No |
Ross et al 201835 | Asthma | Study data | 8 | 1993–1995 | 5–12 | Asthma control | Imputed | Predictor Pursuit | Yes | No | No |
Spyroglou et al 201840 | Asthma | Study data | 1 | 2008–2016 | 1–14.5 | Exacerbation | NR | Bayesian | Yes | No | No |
Huffaker et al 201827 | Asthma | Study data | 1 | 2016–2017 | 5–17 | Exacerbation | Complete case analysis | Random Forest | Yes | No | No |
Shin et al 201828 | Asthma | Registry (EHR) | 1 | 2016 | 6–18 | Hospitalisation | NR | Random Forest | Yes | No | No |
Das et al 201736 | Asthma | Registry (EHR) | 1 | 2013–2014 | ≤18 | Frequent emergency department visits | NR | Logistic Regression | Yes | No | No |
Pite et al 201639 | Wheeze | Study data | 1 | 1993–2006 | ≤7 | Asthma development in adolescence | Complete case analysis | Cluster Analysis | No | No | No |
Van Vliet et al 201643 | Asthma | Study data | 1 | NR | 6–18 | Asthma control | NR | Random Forest | Yes | No | No |
Luo et al 201537 | Asthma | Study data | 4 | 2011–2012 | 2–18 | Asthma control 1 week prior | NR | Multiboost with Decision Stumps | Yes | No | No |
Howrylak et al 201423 | Asthma | Study data | 8 | 1993–1995 | 5–12 | Exacerbation | Imputed | Cluster Analysis | No | No | No |
Farion et al 201324 | Asthma | Registry (clinical records) | 1 | 2000–2004 | 1–17 | Exacerbation severity | Imputed | Naïve Bayes | Yes | No | Yes |
Robroeks et al 201341 | Asthma | Study data | 1 | NR | 6–16 | Exacerbation | NR | SVM | Yes | No | No |
ANN, artificial neural network; EHR, electronic health record; NR, not reported; RCT, randomised controlled trial; SVM, support vector machine.